DOCTOR Doctor introduction

  • 院長 Miyuki Nagaba MIYUKI NAGABA

    Subject in charge

    Regenerative medicine, gynecology, cosmetic dermatology

    Career

    2001
    Graduated from Fujita Health University School of Medicine
    2001
    Worked at Hiroshima University Hospital
    2003
    Worked at Hiroshima General Hospital
    2005
    Worked at Hiroshima Railway Hospital
    2008
    Worked at Hiroshima HART Clinic

    Qualifications/Licenses

    Japanese Society of Obstetrics and Gynecology Specialist

    MIYUKI NAGABA
  • Advisor Yoshito Niki YOSHIHITO NIKI

    Subject in charge

    Infectious Diseases

    Career

    1976
    Graduated from Kawasaki Medical School
    1982
    Kawasaki Medical School, Department of Respiratory Medicine
    1988
    New York City, New York State, USA
    Study abroad at Memorial Sloan-Kettering Cancer Center
    1990
    Lecturer, Department of Health and Medical Sciences, Respiratory Medicine, Kawasaki Medical School
    2006
    Professor, Department of Clinical Infectious Diseases (Endowed Chair), Showa University School of Medicine
    2017
    Specially Appointed Professor, Department of Internal Medicine, Clinical Infectious Diseases, Showa University School of Medicine
    2024
    Professor Emeritus of Showa University, the name of the university will be changed to Showa Medical University in 2025

    Conference presentations and papers

    2010
    President of the 57th General Meeting of the Eastern Japan Branch of the Japanese Society of Chemotherapy
    2013
    The 163rd Kanto Branch Meeting of the Japanese Society for Tuberculosis
    President of the 203rd Kanto Joint Meeting of the Japanese Respiratory Society
    2013
    President of the 57th General Meeting of the Japanese Society of Medical Mycology
    2014
    Chairman of the 1st Tokyo Society for the Study of Intractable Infectious Diseases
    2015
    49th General Chairman of the Pseudomonas Aeruginosa Research Society
    2015
    President of the 63rd General Meeting of the Japanese Society of Chemotherapy, etc.

    Qualifications/Licenses

    Honorary member of the Japanese Society of Internal Medicine

    Honorary member of the Japanese Association of Infectious Diseases

    Japanese Respiratory Society: Distinguished Member

    Honorary member of the Japanese Society for Medical Mycology

    Honorary member of the Japanese Society of Chemotherapy

    Distinguished Member of the Japanese Society for Tuberculosis and Nontuberculous Mycobacterial Diseases

    Japanese Society for Environmental Infection: Distinguished Member

    YOSHIHITO NIKI
  • Director of the Regenerative Medicine Department, Doctor of Medicine Takashi Kuroda YUTAKA KURODA

    Subject in charge

    Regenerative medicine, orthopedics

    Career

    1994
    Graduated from the Department of Economics, Faculty of Economics, Keio University
    1999
    Graduated from St. Marianna University School of Medicine
    1999
    Kyoto University Hospital
    2001
    Resident at Kobe City Medical Center Central Hospital
    2009
    Graduated from Kyoto University Graduate School of Medicine, Department of Orthopedic Surgery
    2012
    Kyoto University Hospital, Department of Orthopedic Surgery, Assistant Professor
    2015
    Assistant Professor, Department of Orthopedic Surgery, Kyoto University Hospital
    2020
    Lecturer, Department of Orthopedic Surgery, Kyoto University Hospital

    Conference presentations and papers

    2010
    Treatment of experimental osteonecrosis of the hip in adult rabbits with a single local injection of recombinant human FGF-2 microspheres. J Bone Miner Metab. 2010;28:606-616.
    2015
    Modified Mostardi approach with ultra-high-molecular-weight polyethylene tape for total hip arthroplasty provides a good rate of union of osteotomized fragments. J Orthop Sci. 2015;20(4):633-641.
    2016
    A pilot study of regenerative therapy using controlled release of rhFGF-2 for patients with precollapse osteonecrosis of the femoral head. Int Orthop.
    2016; 40 (8): 1747-1754.
    2019
    Clinical application of injectable growth factor for bone regeneration: A systematic review. Inflamm Regen. 2019;39:20.
    2019
    Classification of osteonecrosis of the femoral head: Who should have surgery? Bone Joint Res. 2019;8:451-458.
    2021
    Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial. Regen Med. 2021 Jun;16(6):535-548.
    2024
    Investigational regenerative medicine for non-traumatic osteonecrosis of the femoral head: a survey of registered clinical trials. Expert Opin Investig Drugs. 2024 Apr;33(4):405-414.

    Qualifications/Licenses

    Affiliated academic societies:
    Japanese Orthopaedic Association (Councillor), Japanese Hip Society (Councillor), Japanese Society for Regenerative Medicine, Japanese Society for Inflammation and Regenerative Medicine, Japanese Society for Artificial Joint Research, Chubu Disaster Orthopaedic Association, DDS Regenerative Medicine Study Group

    Idiopathic osteonecrosis of the femoral head: Member of the Ministry of Health, Labor and Welfare's meeting and committee member for formulating treatment guidelines

    Specialist of the Japanese Orthopaedic Association, designated doctor for intractable diseases

    YUTAKA KURODA
  • Shigeki Nagura Shigeki Nagara

    Subject in charge

    Regenerative medicine, orthopedics

    Career

    2003
    Graduated from the Department of Administration Engineering, Faculty of Science and Technology, Keio University
    2009
    Graduated from St. Marianna University School of Medicine
    2009
    St. Marianna University School of Medicine Yokohama City Western Hospital Early Clinical Worker
    2011
    Joined the Department of Orthopedic Surgery at Keio University
    2012
    Worked at tertiary emergency hospitals such as Shizuoka Red Cross Hospital, Hiratsuka Municipal Hospital, and Saiseikai Utsunomiya Hospital, as well as other hospitals affiliated with the medical department (experienced trauma and upper limb disorders).
    2025.7
    Appointed Director of Arakawa Nagura Orthopedic Clinic, Medical Corporation

    Conference presentations and papers

    2017
    A case of bone defect caused by infection after ORIF of peri-implant fracture treated with Masquelet reconstruction
    (43rd Annual Meeting of the Japanese Orthopaedic Trauma Association)
    2018
    Seven cases of bone union after bone reconstruction using the Masquelete technique
    (44th Annual Meeting of the Japanese Orthopaedic Trauma Association)
    2019
    Bridging external fixation combined with arthroscopic reduction is effective for intra-articular comminuted distal radius fragments with palmar marginal bone fragments
    (Journal of the Japanese Society for Surgery of the Hand, Vol. 35, No. 5)
    2020
    A comparison of Splint Versus Pinnning the Distal Interphalangeal Joint for Acute Closed tendinous Mallet fingers (J Hand Surg Asian Vol 25(2))
    2020
    Two-stage fixation is effective in postoperative treatment of fresh bony mallet cases
    (63rd Annual Meeting of the Japanese Society for Surgery of the Hand)
    2022
    Current status and future challenges of osteoporosis in upper limb fracture cases at our hospital
    (65rd Annual Meeting of the Japanese Society for Surgery of the Hand)

    Qualifications/Licenses

    Japanese Orthopaedic Association (Japanese Specialist Organization Orthopaedic Surgeon Specialist and Supervising Physician)

    Japanese Society for Surgery of the Hand, Hand Surgery Specialist

    Japanese Orthopaedic Association Certified Rheumatologist/Rehabilitation Doctor

    Japanese Rehabilitation Association Certified Clinician

    Shigeki Nagara
  • Beauty department manager Yoshino Muraishi YOSHIYA MURAISHI

    Subject in charge

    Regenerative medicine, cosmetic dermatology

    Career

    1987
    Graduated from Shinshu University School of Medicine
    1987
    Department of Neurosurgery, University of Tokyo Hospital
    1988
    Department of Plastic Surgery, Juntendo University Hospital
    1988
    Assistant Professor, Department of Plastic Surgery, Juntendo University School of Medicine
    1993
    Chief Physician, Department of Plastic Surgery, Juntendo Izunagaoka Hospital
    1996
    Assistant Professor, Department of Plastic Surgery, Juntendo University School of Medicine
    1997
    Served as director of a major cosmetic surgery clinic

    Qualifications/Licenses

    Specialist certified by the Japanese Society of Plastic Surgery

    Japan Society of Plastic and Reconstructive Surgery

    YOSHIYA MURAISHI
  • Eriko Nemoto ERIKO NEMOTO

    Subject in charge

    Cosmetic dermatology

    Career

    2008
    Graduated from the Faculty of Medicine, Osaka Medical and Pharmaceutical University
    2008
    Kinki Central Hospital, Public School Mutual Aid Association
    2010
    Central Japan Railway Company Nagoya Central Hospital
    2012
    Sakae Clinic Cosmetic Dermatology
    2013
    Director of Ginza Solaria Clinic
    2016
    Clinic Le GINZA Director
    2023
    ALOOP CLINIC & LAB Vice Director

    Qualifications/Licenses

    Ministry of Health, Labor and Welfare Certified Anesthesiologist

    ERIKO NEMOTO
  • Masaki Mukai MASAKI MUKAI

    Subject in charge

    Cosmetic dermatology, regenerative medicine, psychiatry and child psychiatry

    Career

    2020
    Graduated from Teikyo University School of Medicine
    2022
    Nippon Medical School Tama Nagayama Hospital
    2023
    Seibikai Tama Central Hospital
    2024
    Tokyo Metropolitan Children's Medical Center, Child and Adolescent Psychiatry Department

    Qualifications/Licenses

    Affiliated academic society: Japanese Society of Psychiatry and Neurology

    MASAKI MUKAI

Clinic Le GINZA
5 features

Treating aging as a therapeutic target
New regenerative medicine

The aim is to scientifically measure and improve chronic inflammation, a treatable cause of ailments that have traditionally been attributed to aging (an approach to scientifically diagnosing and treating aging).

by specialists in each field
"Team medical care" system

Orthopedic, gynecological, and internal medicine doctors work together to create treatment plans optimized for each patient's condition.

Maximize the body's natural ability to recover
"Cell Revival®"

A unique three-step treatment that improves chronic inflammation and prepares the foundation for stem cell therapy

Based on scientific data
Effect verification

Inflammatory marker testing and EpiClock testing confirm improvement through data, not just feelings

Rest assured even after treatment
Long-term follow-up

Regular checkups and support for up to two years will help maintain and further improve the effectiveness of treatment.

PAGE TOP

Long-standing illnesses and diseases
Would you like to consult with us?